LAMISIL

250 Milligram Tablets

Novartis Pharmaceuticals UK LtdPA0013/045/003

Main Information

Trade NameLAMISIL
Active SubstancesTERBINAFINE
Strength250 Milligram
Dosage FormTablets
Licence HolderNovartis Pharmaceuticals UK Ltd
Licence NumberPA0013/045/003

Group Information

ATC CodeD01BA02 Antifungals for systemic use

Status

Authorised/WithdrawnAuthorised
Licence Issued12/12/1994
Supply StatusSupply through pharmacies only
Dispensing StatusProduct subject to prescription which may be renewed (B)
Marketing StatusTemporarily Not Marketed
Promotion StatusPromotion to Healthcare Professionals only
Conditions of Licence

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back

Latest Changes to Medicine Info & SPC

View all available

Please note changes to the medicine information and summary of product characteristics are only available from the 19/05/2015 onwards. Changes made before this date aren't available online.